Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2009

01-10-2009 | Original Article

Complications in Celiac Disease Under Gluten-Free Diet

Authors: Antonio Tursi, Walter Elisei, Gian Marco Giorgetti, Giovanni Brandimarte, Fabio Aiello

Published in: Digestive Diseases and Sciences | Issue 10/2009

Login to get access

Abstract

We assessed the onset of malignant and nonmalignant complications in a cohort of celiac disease (CD) patients under gluten-free diet (GFD). Five hundred and forty-nine CD patients were retrospectively assessed. Two hundred and fifty-one (45.7%) showed classical, 262 (47.7%) subclinical, and 36 (6.6%) silent form of CD at the time of the diagnosis. The mean time under GFD was 7.13 years (range 1–15 years). Out of 549 patients, 381 (69.4%) were fully compliant, 112/549 (20.4%) reported less than one dietary transgression/month, and 56/549 (10.2%) reported at least one dietary transgression/month. Out of 549 patients, 18 (3.3%) patients developed complications under GFD (seven malignant and 11 nonmalignant complications). Fourteen patients were previously affected by classical CD (5.6% of the overall patients with classical CD), and four were affected by subclinical CD (1.5% of the overall patients with subclinical CD). None of the patients affected by silent CD developed complications. There was no statistical difference between the mean age of the two groups developing complications (P = n.s.). Complications appeared after a mean time under GFD of 6.5 years in classical CD, and after a mean time of 3.5 years in subclinical CD (P = n.s.). Finally, 6/14 (42.8%) patients with classical CD were not fully compliant to GFD, while 2/4 (50%) of subclinical CD patients were not fully compliant to GFD (P = n.s.). Less than 5% of CD patients may develop complications under GFD. Complications seem to affect more classical CD than subclinical CD, and seem to be irrespective of optimal GFD adherence.
Literature
3.
go back to reference Cinquetti M, Trabucchi C, Menegazzi N, Comucci A, Bressan F, Zoppi G. Psychological problems connetted to the dietary restrictions in the adolescent with coeliac disease. Pediatr Med Chir. 1999;21:279–283.PubMed Cinquetti M, Trabucchi C, Menegazzi N, Comucci A, Bressan F, Zoppi G. Psychological problems connetted to the dietary restrictions in the adolescent with coeliac disease. Pediatr Med Chir. 1999;21:279–283.PubMed
6.
go back to reference Cosnes J, Cellier C, Viola S, et al. Groupe D’Etude et de Recherche Sur la Maladie Coeliaque. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol. 2008;6:753–758. doi:10.1016/j.cgh.2007.12.022.PubMedCrossRef Cosnes J, Cellier C, Viola S, et al. Groupe D’Etude et de Recherche Sur la Maladie Coeliaque. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol. 2008;6:753–758. doi:10.​1016/​j.​cgh.​2007.​12.​022.PubMedCrossRef
10.
go back to reference Walker-Smith JA, Guandalini S, Shmitz J. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria for diagnosis of celiac disease. Arch Dis Child. 1990;65:909–911.CrossRef Walker-Smith JA, Guandalini S, Shmitz J. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria for diagnosis of celiac disease. Arch Dis Child. 1990;65:909–911.CrossRef
11.
13.
go back to reference Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”). Gastroenterology. 1992;102:330–354.PubMed Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”). Gastroenterology. 1992;102:330–354.PubMed
15.
go back to reference Hayat M, Caims A, Dixon MF, O’Mahoney S. Quantitation of intraepithelial lymphocytes in human duodenum; what is normal? J Clin Pathol. 2002;55:393–394.PubMed Hayat M, Caims A, Dixon MF, O’Mahoney S. Quantitation of intraepithelial lymphocytes in human duodenum; what is normal? J Clin Pathol. 2002;55:393–394.PubMed
19.
go back to reference Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Regnala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: a 30-year population-based study. Dig Liver Dis. 2006;38:374–380.PubMedCrossRef Viljamaa M, Kaukinen K, Pukkala E, Hervonen K, Regnala T, Collin P. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: a 30-year population-based study. Dig Liver Dis. 2006;38:374–380.PubMedCrossRef
21.
go back to reference Haines ML, Anderson R, Gibson PR. Review article: the evidence base for long term management of celiac disease. Aliment Pharmacol Ther. 2008;28:1042–1066.PubMedCrossRef Haines ML, Anderson R, Gibson PR. Review article: the evidence base for long term management of celiac disease. Aliment Pharmacol Ther. 2008;28:1042–1066.PubMedCrossRef
22.
go back to reference Giorgetti GM, Tursi A, Brandimarte G, Anemona L. Small bowel adenocarcinoma as first sign of coeliac disease. Minerva Gastroenterol Dietol. 2002;48:347–350.PubMed Giorgetti GM, Tursi A, Brandimarte G, Anemona L. Small bowel adenocarcinoma as first sign of coeliac disease. Minerva Gastroenterol Dietol. 2002;48:347–350.PubMed
23.
go back to reference Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428–1435. doi:10.1053/gast.2002.36585.PubMedCrossRef Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428–1435. doi:10.​1053/​gast.​2002.​36585.PubMedCrossRef
25.
go back to reference Alcalde M, Carro J, Rivero M, Fernandez JJ, Saenz De Santamaria JS. MALT lymphoma as first clinical presentation of a celiac disease. Acta Gastroenterol Belg. 1998;61:479–482.PubMed Alcalde M, Carro J, Rivero M, Fernandez JJ, Saenz De Santamaria JS. MALT lymphoma as first clinical presentation of a celiac disease. Acta Gastroenterol Belg. 1998;61:479–482.PubMed
29.
go back to reference Wolber R, Owen D, Del Buono L, Appelmann H, Freeman H. Lymphocytic gastritis in patients with celiac sprue or sprue-like intestinal disease. Gastroenterology. 1990;98:310–315.PubMed Wolber R, Owen D, Del Buono L, Appelmann H, Freeman H. Lymphocytic gastritis in patients with celiac sprue or sprue-like intestinal disease. Gastroenterology. 1990;98:310–315.PubMed
31.
go back to reference D’Onofrio F, Miele L, Diaco M, et al. Sjögren’s syndrome in a celiac patient: searching for environmental triggers. Int J Immunopathol Pharmacol. 2006;19:445–448.PubMed D’Onofrio F, Miele L, Diaco M, et al. Sjögren’s syndrome in a celiac patient: searching for environmental triggers. Int J Immunopathol Pharmacol. 2006;19:445–448.PubMed
38.
go back to reference Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007;13:163–174. doi:10.1093/humupd/dml054.PubMedCrossRef Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update. 2007;13:163–174. doi:10.​1093/​humupd/​dml054.PubMedCrossRef
44.
go back to reference Silano M, Volta U, De Vincenzi A, Sessì M, De Vincenzi M. Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci. 2008;53:972–976. doi:10.1007/s10620-007-9952-8.PubMedCrossRef Silano M, Volta U, De Vincenzi A, Sessì M, De Vincenzi M. Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease. Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci. 2008;53:972–976. doi:10.​1007/​s10620-007-9952-8.PubMedCrossRef
45.
go back to reference Tursi A, Brandimarte G, Giorgetti GM, Gigliobianco A. Endoscopic features of celiac disease in adults and their correlation with age, histological damage, and clinical form of the disease. Endoscopy. 2002;34:787–792. doi:10.1055/s-2002-34255.PubMedCrossRef Tursi A, Brandimarte G, Giorgetti GM, Gigliobianco A. Endoscopic features of celiac disease in adults and their correlation with age, histological damage, and clinical form of the disease. Endoscopy. 2002;34:787–792. doi:10.​1055/​s-2002-34255.PubMedCrossRef
46.
go back to reference Brandimarte G, Tursi A, Giorgetti GM. Changing trends in clinical form of coeliac disease: which is now the main form of coeliac disease in clinical practice? Minerva Gastroenterol Dietol. 2002;47:121–130. Brandimarte G, Tursi A, Giorgetti GM. Changing trends in clinical form of coeliac disease: which is now the main form of coeliac disease in clinical practice? Minerva Gastroenterol Dietol. 2002;47:121–130.
Metadata
Title
Complications in Celiac Disease Under Gluten-Free Diet
Authors
Antonio Tursi
Walter Elisei
Gian Marco Giorgetti
Giovanni Brandimarte
Fabio Aiello
Publication date
01-10-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0595-1

Other articles of this Issue 10/2009

Digestive Diseases and Sciences 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine